RSCI (Redwood Scientific Technologies) Days Sales Outstanding: 0.00 (As of Dec. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Redwood Scientific Technologies Days Sales Outstanding?

Redwood Scientific Technologies RSCI -99.10% Days Sales Outstanding is 0.00 as of Dec. 2023.

Redwood Scientific Technologies's average Accounts Receivable for the six months ended in Dec. 2023 was $0.00 Mil. Redwood Scientific Technologies's Revenue for the six months ended in Dec. 2023 was $0.00 Mil.

The historical rank and industry rank for Redwood Scientific Technologies's Days Sales Outstanding or its related term are showing as below:

RSCI's Days Sales Outstanding is not ranked *
in the Drug Manufacturers industry.
Industry Median: 71.955
* Ranked among companies with meaningful Days Sales Outstanding only.

Redwood Scientific Technologies's Days Sales Outstanding stayed the same from Dec. 2021 (0.00) to Dec. 2023 (0.00).

Redwood Scientific Technologies  (OTCPK:RSCI) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Redwood Scientific Technologies Days Sales Outstanding Related Terms

Redwood Scientific Technologies Days Sales Outstanding Historical Data

* Premium members only.

The historical data trend for Redwood Scientific Technologies's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redwood Scientific Technologies Days Sales Outstanding Chart

Redwood Scientific Technologies Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
0.00 0.00 0.00 0.00

Redwood Scientific Technologies Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding 0.00 0.00 0.00 0.00

RSCI vs RAPH, FLGC, TXMD: Days Sales Outstanding Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Redwood Scientific Technologies's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Redwood Scientific Technologies Days Sales Outstanding vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Redwood Scientific Technologies's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Redwood Scientific Technologies's Days Sales Outstanding falls into.


Redwood Scientific Technologies Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Redwood Scientific Technologies's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0 + 0) / 1 ) / 0*365
=0 / 0*365
=N/A

Redwood Scientific Technologies's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0 + 0) / 1 ) / 0*365 / 2
=0 / 0*365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Sales Outstanding →
What does a Days Sales Outstanding of 0.00 mean?
Redwood Scientific Technologies (RSCI) has a Days Sales Outstanding of 0.00 as of Dec. 2023. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Redwood Scientific Technologies and its competitors.
Is Redwood Scientific Technologies' Days Sales Outstanding too high?
Redwood Scientific Technologies' current Days Sales Outstanding is 0.00.
How does Redwood Scientific Technologies' Days Sales Outstanding compare to RAPH and FLGC?
Redwood Scientific Technologies' Days Sales Outstanding of 0.00 can be compared against companies in the Drug Manufacturers industry. The industry median Days Sales Outstanding is 71.96. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Drug Manufacturers company?
The median Days Sales Outstanding among Drug Manufacturers companies is 71.96, based on 948 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Redwood Scientific Technologies and its competitors. For the Drug Manufacturers industry, the median Days Sales Outstanding is 71.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Redwood Scientific Technologies's current Days Sales Outstanding is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redwood Scientific Technologies stock overvalued right now?
Redwood Scientific Technologies (RSCI) has a current Days Sales Outstanding of 0.00. The current Days Sales Outstanding is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Redwood Scientific Technologies (RSCI), the current Days Sales Outstanding is 0.00 as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Redwood Scientific Technologies Business Description

Address 418 Broadway, STE 4872, Albany, NY, USA, 12207
Redwood Scientific Technologies Inc is a pharmaceutical delivery company that develops, operates, and markets over-the-counter products in a sublingual oral thin film strip. RSCI has begun clinical trials on two new products to market for stopping the addiction to nicotine.